Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kalys is a French company specializing in the development, production, and distribution of natural polymers and hydrocolloids for the pharmaceutical, cosmetic, and food industries. The company provides a wide range of functional ingredients, including alginates, carrageenans, and galactomannans, which are used as excipients, thickening agents, and stabilizers in drug formulations and personal care products. Kalys is particularly recognized for its expertise in texturizing agents and its ability to provide customized solutions for specific industrial applications. Beyond its industrial supply business, the company also operates in the molecular gastronomy sector, providing high-quality additives for culinary innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kalys.